Chromadex Corp Net Worth
Chromadex Corp Net Worth Breakdown | CDXC |
Chromadex Corp Net Worth Analysis
Chromadex Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Chromadex Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Chromadex Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Chromadex Corp's net worth analysis. One common approach is to calculate Chromadex Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Chromadex Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Chromadex Corp's net worth. This approach calculates the present value of Chromadex Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Chromadex Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Chromadex Corp's net worth. This involves comparing Chromadex Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Chromadex Corp's net worth relative to its peers.
Enterprise Value |
|
To determine if Chromadex Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chromadex Corp's net worth research are outlined below:
| Chromadex Corp is way too risky over 90 days horizon | |
| Chromadex Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 83.57 M. Net Loss for the year was (4.94 M) with profit before overhead, payroll, taxes, and interest of 42.8 M. | |
| Chromadex Corp has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 16b-3 |
Chromadex Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chromadex Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chromadex Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Chromadex Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chromadex Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chromadex Corp backward and forwards among themselves. Chromadex Corp's institutional investor refers to the entity that pools money to purchase Chromadex Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 192.3 K | Bank Of New York Mellon Corp | 2024-06-30 | 190.4 K | Winton Capital Group Ltd | 2024-09-30 | 178.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 158.1 K | Gamco Investors, Inc. Et Al | 2024-09-30 | 143.2 K | Charles Schwab Investment Management Inc | 2024-09-30 | 140.2 K | Ubs Group Ag | 2024-06-30 | 139.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 139.5 K | Strs Ohio | 2024-09-30 | 104.1 K | Vanguard Group Inc | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 3.1 M |
Follow Chromadex Corp's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 579.75 M.Market Cap |
|
Project Chromadex Corp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.10) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.17) | (0.18) |
When accessing Chromadex Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Chromadex Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chromadex Corp's profitability and make more informed investment decisions.
Please note, the presentation of Chromadex Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chromadex Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chromadex Corp's management manipulating its earnings.
Evaluate Chromadex Corp's management efficiency
As of November 28, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.38 | 0.24 | |
| Tangible Book Value Per Share | 0.37 | 0.23 | |
| Enterprise Value Over EBITDA | (21.36) | (22.43) | |
| Price Book Value Ratio | 3.77 | 3.58 | |
| Enterprise Value Multiple | (21.36) | (22.43) | |
| Price Fair Value | 3.77 | 3.58 | |
| Enterprise Value | 205.9 M | 216.2 M |
The management strategies employed by Chromadex Corp's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Enterprise Value Revenue 5.8959 | Revenue 91.7 M | Quarterly Revenue Growth 0.312 | Revenue Per Share 1.215 | Return On Equity 0.0482 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chromadex Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chromadex Corp Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Chromadex Corp Earnings per Share Projection vs Actual
Chromadex Corp Corporate Management
| Kendall Knysch | Head Partnerships | Profile | |
| Heather Blarcom | Senior Secretary | Profile | |
| Andrew Shao | Senior Affairs | Profile | |
| Chu Yan | Managing Pacific | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.